FDA Drugs (New Approvals & NDA)Original article
FDA Alerts Health Care Providers to Cases of Neurologic Complications from General Anesthesia Linked to Genetic Variant in Patients of Maternal Venezuelan Ancestry
RegulatorysevofluraneNegative
AI Analysis
Summary
The FDA is investigating safety concerns with sevoflurane and other general anesthetics following reports of severe neurologic complications and deaths in patients of maternal Venezuelan ancestry who carry a specific genetic variant.
Outcome Details
FDA investigating safety of sevoflurane and other general anesthetics based on reports of neurologic complications and death in patients with genetic variant of maternal Venezuelan ancestry
Importance:6/10
Sentiment:
-0.80
FDA safety alertsevofluraneneurologic adverse eventsgenetic variantanesthesia safetypatient deaths
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on July 2, 2026 8:07 PM